Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival

Pancreas. 2013 Jan;42(1):60-6. doi: 10.1097/MPA.0b013e318258fda8.

Abstract

Objectives: The objective of the study was to verify if histopathological differentiation of ampullary carcinoma after surgical resection may be related to survival.

Methods: The prognostic role of an accurate histological and immunohistochemical classification has been investigated in a multicentric series of carcinoma of the ampulla of Vater. Immunohistochemical expression of cytokeratin 7 (CK7) and CK20 were analyzed in the different morphological histotypes of ampullary cancers, and results were compared with overall survival.

Results: Of 72 ampullary cancers, 48.6% were classified as pancreaticobiliary-type carcinomas, 43.1% were classified as intestinal-type carcinomas, and 8.3% were classified as "unusual"-type carcinomas. Cytokeratin 20 was expressed in 28 (90.3%) of the 31 intestinal-type carcinomas, whereas it was always negative in the pancreaticobiliary histotype; CK7 was expressed in 32 (91.4%) of the 35 pancreaticobiliary-type carcinomas and in 18 (58.1%) of the 31 intestinal-type carcinomas. By univariate analysis, overall survival was influenced significantly by pathological T factor, lymph node involvement, and histological/immunohistochemical subtyping. Furthermore, using a multivariate Cox regression model, lymph node metastasis and CK20 were identified as significant independent factors related to prognosis.

Conclusion: Our results prove the clinical use of ampullary cancer subclassification based on different histotypes and indicate the useful role of the CK7/CK20 expression profile for consistent histopathological classification and prognostic relevance.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Ampulla of Vater / immunology*
  • Ampulla of Vater / pathology*
  • Ampulla of Vater / surgery
  • Biomarkers, Tumor / analysis*
  • Carcinoma / diagnosis*
  • Carcinoma / immunology
  • Carcinoma / mortality
  • Carcinoma / pathology
  • Carcinoma / surgery
  • Common Bile Duct Neoplasms / diagnosis*
  • Common Bile Duct Neoplasms / immunology
  • Common Bile Duct Neoplasms / mortality
  • Common Bile Duct Neoplasms / pathology
  • Common Bile Duct Neoplasms / surgery
  • Female
  • Humans
  • Immunophenotyping* / methods
  • Italien
  • Kaplan-Meier Estimate
  • Keratin-20 / analysis
  • Keratin-7 / analysis*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • KRT20 protein, human
  • KRT7 protein, human
  • Keratin-20
  • Keratin-7